Thomas von Aubel

Capsulution Pharma AG is a leading nanotechnology enterprise specialized in the customer-specific development of life-science products. As a spin-off of the Max Planck Society, its enterprise is a pioneer in the commercial utilization of the latest research results from the field of nanotechnology. They are opening up new frontiers by applying nanotechnology to the modern challenges of pharmaceutical therapy, medical technology and diagnostics. For this they use the years of expertise its staff and partners can offer as well as its internationally patented technologies for the production of multi-functional nanocapsules and nanocomplexes. Its nanocapsules and complexes are intelligent 'transport containers', so small that around 3 billion fit on the head of a single pin. Special processes allow them to furnish these tiny transport containers with a combination of pharmaceutical, biochemical, electrical, optical and magnetic properties. On this basis they are able to develop solutions that are always innovative and market-oriented, for example for more targeted and more effective drug delivery. Thanks to the right combination of specialized knowledge innovative spirit and reliability, Capsulution has been able to play the multiple roles of initiator, developer and consultant on the way to many a successful product.